Skip to main content

Table 2 Averaged relative volumes of GTVs covered by 95% of prescription dose ( GV 95 ) for different planning strategies

From: Evaluation and comparison of New 4DCT based strategies for proton treatment planning for lung tumors

  Case A B C D E F G H I J K L MGV 95 STDGV 95
GV 95 (%) CVCT plan 64.9 84.1 97.5 99.8 97.3 95.1 93.8 97.0 99.9 99.8 100 98.4 94.1 10.2
MIP3 plan 82.2 88.3 97.1 100 96.9 100 96.3 100 100 99.8 99.7 100 96.7 5.7
AVG plan 64.0 86.3 90.9 96.3 95.3 99.8 91.5 100 100 99.7 100 100 93.6 10.4
EE plan 69.1 89.7 96.3 99.8 96.5 99.9 94.4 100 100 99.8 100 99.8 95.4 8.9
GM LD (Gy) CVCT plan 1.0 1.9 3.6 2.9 3.6 4.9 6.6 4.1 5.6 7.3 11.1 11.7   
MIP3 plan 1.1 2.0 3.7 3.0 3.8 5.1 6.9 4.5 5.3 7.3 11.5 11.0   
AVG plan 0.9 2.0 2.9 2.5 3.4 4.1 5.5 4.0 4.5 6.2 11.3 11.0   
  EE plan 0.8 2.0 3.1 2.5 3.4 4.2 5.7 3.9 4.7 6.5 11.5 11.0   
  1. Mean ipsilateral lung dose (GM LD ) (Gy) from CVCT, MIP3, AVG and EE plans (treatment uncertainties not included).